December 16, 2020
A new study shows that implementing PrEP distribution within a community-based syringe services program gets the medication into the hands of women who inject drugs a population disproportionately impacted by HIV.
When taken daily, pre-exposure prophylaxis, or PrEP, is a highly effectiveway to prevent HIV transmission, according to the Centers for Disease Control and Prevention. Now a new study shows that implementing PrEP distribution within a community-based syringe services program gets the medication into the hands of women who inject drugs a population disproportionately impacted by HIV. The results, from researchers at Drexel University’s Dornsife School of Public Health, Dornsife School of Public Health, were recently published in the